Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek™), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: Final results of a multicenter compassionate use trial
- Sima Jeha
- , H. Kantarjian
- , D. Irwin
- , V. Shen
- , S. Shenoy
- , S. Blaney
- , B. Camitta
- , C. H. Pui
Research output: Contribution to journal › Article › peer-review
156
Link opens in a new tab
Scopus
citations